Web Analytics

3 Latest Announced Rounds

  • $2,000,000
    Seed

    2 Investors

    Information Services
    Mar 19th, 2026
  • $20,000,000
    Unknown

    5 Investors

    Software Development
    Mar 19th, 2026
  • $8,000,000
    Seed

    1 Investors

    Computer & Network Security
    Mar 19th, 2026
$812.51M Raised in 55 Funding Rounds in the past 7 Days - View All

Funding Round Profile

KROMATID®

start up
United States - Longmont, Colorado
  • 21/08/2025
  • Series C
  • $8,000,000

Revolutionizing gene editing analysis for precision medicine and cutting-edge research.

For cell and gene therapy researchers, biotech and pharma companies, and regulatory professionals, KROMATID’s KROMASURE Platform is the genomic characterization solution that provides high-confidence, single-cell insights into chromosomal integrity, structural variants, and transgene mapping.
Unlike traditional sequencing methods, our technology directly visualizes up to thousands of single cells at a time, offering scalable, actionable data with unprecedented clarity, helping you confidently advance research and meet FDA regulatory requirements.

Visit our website to learn how we can support your research.


Related People

Jim ChomasFounder

Jim Chomas United States - Denver, Colorado

N/A